25 May 2013
Keywords: antisoma, unveils, egm, resolutions, reports, as404, uk-based
Article | 04 June 2007
UK-based cancer drug developer Antisoma says that decisions taken at a recent extraordinary general meeting, including granting the firm power
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 June 2007
24 May 2013
© 2013 thepharmaletter.com